Concepedia

Author

Deborah E. Banker

Fred Hutch Cancer Center

Also Known As

D E Banker, D.E. Banker, Deborah Banker, Deborah E Banker, Deborah E. Banker

32

Publications

1.4K

Citations

17

H-Index

46

Concepts

All Affiliations

Fred Hutch Cancer CenterUniversity of WashingtonNew Mexico Cancer CenterUniversity of New MexicoCape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa
DE

About

Deborah E. Banker is an author at Fred Hutch Cancer Center specializing in medicine, cell biology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

365

2

Public Health

3

3

85

3

Health Sciences

2

2

49

4

Biology

2

2

75

5

Engineering

1

1

45

Deborah E. Banker

×

20

Publications

1.4K

Citations

16

H-Index

YearCitations

Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5)

Sara Garrido, Frederick R. Appelbaum, Cheryl L. Willman,

Experimental Hematology

2001

240

Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses

Henry Y. Li, Frederick R. Appelbaum, Cheryl L. Willman,

Blood

2003

205

Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AML by the addition of pravastatin to idarubicin + high-dose Ara-C: a phase 1 study

Steven M. Kornblau, Deborah E. Banker, Derek L. Stirewalt,

Blood

2006

133

Measurement of Spontaneous and Therapeutic Agent-Induced Apoptosis With BCL-2 Protein Expression in Acute Myeloid Leukemia

Deborah E. Banker, Mark Groudine, Tom Norwood,

Blood

1997

105

Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cells

Deborah E. Banker, S Mayer, Henry Y. Li,

Blood

2004

95

The peripheral benzodiazepine receptor ligand PK11195 overcomes different resistance mechanisms to sensitize AML cells to gemtuzumab ozogamicin

Roland B. Walter, Brian W. Raden, Michelle R. Cronk,

Blood

2004

92

Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression

Derek L. Stirewalt, F R Appelbaum, Cheryl L. Willman,

Leukemia Research

2003

67

The thyroid hormone receptor gene (c-erbA alpha) is expressed in advance of thyroid gland maturation during the early embryonic development of Xenopus laevis.

Deborah E. Banker, Jeannette Bigler, Robert N. Eisenman

Molecular and Cellular Biology

1991

53

PK11195, a peripheral benzodiazepine receptor (pBR) ligand, broadly blocks drug efflux to chemosensitize leukemia and myeloma cells by a pBR-independent, direct transporter-modulating mechanism

Roland B. Walter, Jason Pirga, Michelle R. Cronk,

Blood

2005

51

The t(8;21) translocation is not consistently associated with high Bcl-2 expression in de novo acute myeloid leukemias of adults.

Deborah E. Banker, Jerald P. Radich, Abram Becker,

PubMed

1998

50

Page 1